J Arnold Wealth Management CO Acelrx Pharmaceuticals Inc Transaction History

J Arnold Wealth Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Sep 08, 2021	SELL	$1.25 - $2.77 $500 - $1,108	-400 Reduced 2.99%	13,000 $22,000
Q4 2020 Sep 08, 2021	SELL	$1.18 - $1.98 $10,030 - $16,830	-8,500 Reduced 38.81%	13,400 $17,000
Q3 2020 Sep 08, 2021	SELL	$1.01 - $1.81 $11,615 - $20,815	-11,500 Reduced 34.43%	21,900 $31,000
Q1 2020 Sep 08, 2021	BUY	$0.76 - $2.07 $11,704 - $31,877	15,400 Added 85.56%	33,400 $39,000
Q4 2019 Sep 08, 2021	BUY	$1.66 - $2.4 $29,880 - $43,200	18,000 New	18,000 $38,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of J Arnold Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on J Arnold Wealth Management CO with notifications on news.